In an asymptomatic 31‑year‑old male with a positive nucleic‑acid amplification test for Ureaplasma species, what is the recommended treatment approach?

Treatment Approach for Asymptomatic Ureaplasma Detection

Do Not Treat This Patient

An asymptomatic 31-year-old male with positive Ureaplasma testing should not receive antimicrobial therapy based solely on the laboratory result. 1, 2

---

Rationale for Withholding Treatment

Asymptomatic Carriage Is Common and Non-Pathogenic

• Ureaplasma colonizes 40–80% of sexually active adults without causing disease, making detection in asymptomatic individuals clinically meaningless. 2
• The CDC explicitly states that patients with positive Mycoplasma hominis and Ureaplasma parvum results should not be treated based solely on these findings. 1
• The European STI Guidelines Editorial Board confirms that routine testing and treatment of asymptomatic men for Ureaplasma are not recommended because we lack evidence that treatment provides more benefit than harm. 2

No Objective Evidence of Urethritis

• This patient has no urethral discharge, which is the cardinal sign of urethritis. 3

• Treatment should only be considered if objective urethritis is documented by any of the following criteria: 1

  • Mucopurulent or purulent urethral discharge on examination
  • Gram stain showing ≥5 WBCs per oil immersion field
  • Positive leukocyte esterase test on first-void urine
  • Microscopic examination showing ≥10 WBCs per high-power field in first-void urine

• The CDC is clear that urethral symptoms alone without objective laboratory findings are insufficient to diagnose urethritis. 4

---

When to Reconsider Testing and Treatment

If Symptoms Develop

• Only test for Ureaplasma if the patient develops documented urethritis symptoms such as mucopurulent discharge, dysuria, or urethral pruritis. 3
• Before attributing symptoms to Ureaplasma, exclude true STI pathogens first: Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis. 1, 2

Criteria for Treatment (All Must Be Present)

Treatment is justified only if all of the following conditions are met: 1

1. Objective urethritis is documented using the criteria above
2. N. gonorrhoeae, C. trachomatis, M. genitalium, and T. vaginalis are excluded
3. The detected organism is U. urealyticum (not U. parvum) with high load on quantitative testing
4. Symptoms persist despite appropriate evaluation

---

Treatment Regimen (If Criteria Are Met)

First-Line Therapy

• Doxycycline 100 mg orally twice daily for 7 days is the preferred regimen. 1

Alternative Regimens

• Azithromycin 1 g orally as a single dose 1
• Erythromycin base 500 mg orally four times daily for 7 days 1

Partner Management (Only If Patient Is Treated)

• All sexual partners with contact within 60 days must be evaluated and treated if the index patient receives treatment. 1
• Both patient and partners must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of the 7-day regimen. 1

---

Critical Pitfalls to Avoid

Do Not Treat Based on PCR Positivity Alone

• Commercial multiplex PCR assays that include Ureaplasma have worsened inappropriate testing and treatment, leading to antimicrobial resistance and unnecessary costs. 2
• Asymptomatic detection does not indicate infection—it reflects colonization in the vast majority of cases. 2

Distinguish Between U. urealyticum and U. parvum

• U. urealyticum (biovar 2) with high bacterial load is associated with symptomatic urethritis, whereas U. parvum (biovar 1) is not. 5
• U. parvum loads do not differ between symptomatic and asymptomatic men, suggesting it is a commensal organism. 5
• If testing is performed, use quantitative species-specific molecular tests to differentiate the two species and assess bacterial load. 2

Avoid Empiric Treatment Without Objective Findings

• The CDC permits deferral of antimicrobial therapy only when no objective signs of urethritis are present and the patient is reliable for follow-up. 4
• Symptoms alone without objective signs are insufficient to justify treatment. 4

---

Patient Counseling

• Reassure the patient that Ureaplasma detection in the absence of symptoms does not require treatment. 1, 2
• Instruct the patient to return only if symptoms develop, such as urethral discharge, dysuria, or discomfort. 1
• Explain that unnecessary antibiotic use contributes to resistance and may harm the normal microbiota. 2